Sue Stephens

Tumour necrosis factor alpha in stool as a marker of intestinal inflammation

Christian Braegger, Stephen J. Nicholls, Simon Murch et al. · The Lancet · 1992 · 696 citations

Veterinary Medicine, Immunology, Pathology +14

Mechanism of action of certolizumab pegol (CDP870): In vitro comparison with other anti-tumor necrosis factor α agents

Andrew Nesbitt, Gianluca Fossati, Marianne Bergin et al. · Inflammatory Bowel Diseases · 2007 · 473 citations

Veterinary Medicine, Immunology, Pharmacology +17

Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis

Charles J. Fisher, Steven M. Opal, Jean-François Dhainaut et al. · Critical Care Medicine · 1993 · 431 citations

Pharmacy, Immunology, Pharmacokinetics +17

Antibody-targeted chemotherapy with CMC-544: a CD22-targeted immunoconjugate of calicheamicin for the treatment of B-lymphoid malignancies

John F. DiJoseph, Douglas Armellino, Erwin R. Boghaert et al. · Blood · 2003 · 356 citations · Full text

Medicine, Medicinal Chemistry, Oncology +11

Significance of systemic endotoxaemia in inflammatory bowel disease.

Keith Gardiner, M I Halliday, G R Barclay et al. · Gut · 1995 · 232 citations · Full text

Veterinary Medicine, Immunology, Pathobiology +17